HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jürgen Wollenhaupt Selected Research

Jürgen Wollenhaupt Research Topics

Disease

24Rheumatoid Arthritis
04/2022 - 06/2004
9Psoriatic Arthritis
04/2022 - 06/2004
5Necrosis
08/2014 - 07/2009
3Diarrhea
04/2022 - 06/2004
3Nausea
04/2022 - 02/2013
3Headache (Headaches)
04/2022 - 02/2013
3Psoriasis (Pustulosis Palmaris et Plantaris)
06/2014 - 06/2004
2Infections
04/2022 - 07/2017
2Nasopharyngitis
08/2020 - 02/2013
2Ankylosing Spondylitis
11/2016 - 11/2013
2Rheumatic Diseases (Rheumatism)
08/2014 - 02/2014
1Dyspepsia (Indigestion)
04/2022
1Breakthrough Infections
01/2022
1Respiratory Tract Infections (Respiratory Tract Infection)
08/2020
1Pain (Aches)
07/2020
1Arthritis (Polyarthritis)
07/2020
1Neoplasms (Cancer)
07/2017
1Herpes Zoster
07/2017
1Non-Radiographic Axial Spondyloarthritis
11/2016
1Axial Spondyloarthritis
11/2016
1Abscess
11/2013
1Urinary Tract Infections (Urinary Tract Infection)
02/2013
1Osteitis
04/2011
1Synovitis
04/2011
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
04/2011

Drug/Important Bio-Agent (IBA)

10tofacitinibIBA
04/2022 - 02/2013
8Janus Kinase InhibitorsIBA
04/2022 - 02/2013
6Antirheumatic Agents (DMARD)IBA
01/2016 - 04/2011
5golimumabFDA Link
01/2016 - 07/2009
4apremilastIBA
08/2020 - 06/2014
4Methotrexate (Mexate)FDA LinkGeneric
06/2018 - 07/2009
3Certolizumab PegolFDA Link
01/2018 - 12/2012
3Phosphodiesterase 4 InhibitorsIBA
01/2018 - 06/2014
3Biological ProductsIBA
11/2016 - 11/2013
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2015 - 07/2009
2ametantrone (HAQ)IBA
07/2020 - 04/2011
2Abatacept (Orencia)FDA Link
06/2015 - 04/2011
2secukinumabIBA
02/2014 - 11/2013
2Monoclonal AntibodiesIBA
02/2014 - 11/2013
1VaccinesIBA
01/2022
1Janus KinasesIBA
10/2020
1C-Reactive ProteinIBA
07/2020
1Prostaglandins AIBA
07/2020
1GlucocorticoidsIBA
06/2018
1Naproxen (Naprosyn)FDA LinkGeneric
11/2016
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
11/2016
1Infliximab (Remicade)FDA Link
11/2016
1Tumor Necrosis Factor InhibitorsIBA
01/2015
1InterleukinsIBA
02/2014
1CytokinesIBA
11/2013
1Interleukin-17 (Interleukin 17)IBA
11/2013
1Immunologic Factors (Immunomodulators)IBA
02/2013
1Adalimumab (Humira)FDA Link
12/2012
1tocilizumab (atlizumab)FDA Link
11/2011
1Leflunomide (Arava)FDA LinkGeneric
06/2004
1Alanine Transaminase (SGPT)IBA
06/2004
1pyrimidineIBA
06/2004

Therapy/Procedure

7Therapeutics
01/2017 - 01/2013
2Aftercare (After-Treatment)
01/2015 - 07/2009
1Biological Therapy
06/2014
1Secondary Prevention
11/2012
1Subcutaneous Injections
07/2009